INTRODUCTION: Racial/ethnic disparities in colorectal cancer (CRC) screening exist. The literature suggests that differential treatment by race may influence health behaviors and health outcomes. OBJECTIVE: We examined the impact of Reactions to Race-based treatment on being up-to-date with colorectal cancer screening with endoscopy or fecal occult blood testing (FOBT) among non-Hispanic White, non-Hispanic Black, and Hispanic men and women aged > or = 50 years. DESIGN: Secondary data analysis of the Reactions to Race Module on the 2002 and 2004 Behavioral Risk Factor Surveillance System (BRFSS) was performed. Using logistic regression, we examined the strength of association between Reactions to Race-based treatment variables with up-to-date CRC screening tests after adjusting for demographic and access variables. MAIN OUTCOME MEASURES: CRC screening tests were analyzed independently as FOBT within 2 years (n = 30,134) and endoscopy (colonoscopy or sigmoidoscopy) within 5 years (n = 30,210). RESULTS: Among Whites, 34% reported FOBT, compared with 30.6% of Blacks and 15.3% of Hispanics (P < .05). Forty-five percent of Whites reported endoscopy, compared with 40.7% of Blacks and 32.1% of Hispanics (P < .05). After adjusting for sociodemographic characteristics, Hispanics who always thought about their race were 73% (OR = .27; 95% CI: .13-.57) less likely to receive FOBT. CONCLUSIONS: While screening disparities were largest among persons without insurance and a usual source of care, more research is needed to understand the influence of Reactions to Race-based treatment as an additional barrier to CRC screening.
INTRODUCTION: Racial/ethnic disparities in colorectal cancer (CRC) screening exist. The literature suggests that differential treatment by race may influence health behaviors and health outcomes. OBJECTIVE: We examined the impact of Reactions to Race-based treatment on being up-to-date with colorectal cancer screening with endoscopy or fecal occult blood testing (FOBT) among non-Hispanic White, non-Hispanic Black, and Hispanic men and women aged > or = 50 years. DESIGN: Secondary data analysis of the Reactions to Race Module on the 2002 and 2004 Behavioral Risk Factor Surveillance System (BRFSS) was performed. Using logistic regression, we examined the strength of association between Reactions to Race-based treatment variables with up-to-date CRC screening tests after adjusting for demographic and access variables. MAIN OUTCOME MEASURES: CRC screening tests were analyzed independently as FOBT within 2 years (n = 30,134) and endoscopy (colonoscopy or sigmoidoscopy) within 5 years (n = 30,210). RESULTS: Among Whites, 34% reported FOBT, compared with 30.6% of Blacks and 15.3% of Hispanics (P < .05). Forty-five percent of Whites reported endoscopy, compared with 40.7% of Blacks and 32.1% of Hispanics (P < .05). After adjusting for sociodemographic characteristics, Hispanics who always thought about their race were 73% (OR = .27; 95% CI: .13-.57) less likely to receive FOBT. CONCLUSIONS: While screening disparities were largest among persons without insurance and a usual source of care, more research is needed to understand the influence of Reactions to Race-based treatment as an additional barrier to CRC screening.
Authors: Sarah McKetta; Mark L Hatzenbuehler; Charissa Pratt; Lisa Bates; Bruce G Link; Katherine M Keyes Journal: Ann Epidemiol Date: 2017-07-13 Impact factor: 3.797
Authors: Chanita Hughes Halbert; Frances K Barg; Carmen E Guerra; Judy A Shea; Katrina Armstrong; Monica Ferguson; Benita Weathers; James Coyne; Andrea B Troxel Journal: J Gen Intern Med Date: 2011-07-06 Impact factor: 5.128
Authors: Leah L Zullig; William R Carpenter; Dawn Provenzale; Morris Weinberger; Bryce B Reeve; George L Jackson Journal: J Clin Oncol Date: 2013-09-03 Impact factor: 44.544